Key facts
- This page summarizes Carlos Paya V's Form 4 filing for Vaxcyte, Inc. (PCVX).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 10 Dec 2024, 16:14.
Carlos Paya V - 06 Dec 2024 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)
- Reporting relationship
- Director
- Issuer ticker
- PCVX
- Reported as of
- 06 Dec 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Dec 2024, 16:14:54 UTC
- Prior SEC filing
- 10 Jun 2024
- Next SEC filing
- 19 May 2025
- Source filing
- View source filing
- Reporting owner signature
- Carlos V. Paya, by /s/ Peter N. Efremenko, Attorney-In-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Carlos Paya V filed Form 4 for Vaxcyte, Inc. (PCVX) on 10 Dec 2024.
Change
- Previous filing in this sequence was filed on 10 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PCVX
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -2,500
- Change %
- -62%
- Price
- $0.000000
- Shares after
- 1,550
- Date
- 06 Dec 2024
- Ownership
- Direct
- Footnotes
- F1, F2
PCVX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,500
- Change %
- +80%
- Price
- $0.000000
- Shares after
- 5,625
- Date
- 06 Dec 2024
- Ownership
- By Family Trust
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PCVX
transaction
Derivative
Stock Option (right to buy)
Gift
- Transaction value
- $0
- Shares
- -7,250
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 09 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,250
- Exercise price
- $72.51
- Footnotes
- F1, F4
PCVX
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +7,250
- Change %
- Price
- $0.000000
- Shares after
- 7,250
- Date
- 09 Dec 2024
- Ownership
- By Family Trust
- Underlying class
- Common Stock
- Underlying amount
- 7,250
- Exercise price
- $72.51
- Footnotes
- F1, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person.
Footnote F2
As previously disclosed in Reporting Person's Form 4 filed on June 10, 2024, this represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
Footnote F3
Shares are held directly by a trust for the sole benefit of the Reporting Person.
Footnote F4
The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.